IL69525A0 - Spiro(2h-1,4-benzodioxepin-3(5h)4'piperidine and 3'-pyrrolidino)compounds,a process for preparing the same and their use as medicaments - Google Patents

Spiro(2h-1,4-benzodioxepin-3(5h)4'piperidine and 3'-pyrrolidino)compounds,a process for preparing the same and their use as medicaments

Info

Publication number
IL69525A0
IL69525A0 IL69525A IL6952583A IL69525A0 IL 69525 A0 IL69525 A0 IL 69525A0 IL 69525 A IL69525 A IL 69525A IL 6952583 A IL6952583 A IL 6952583A IL 69525 A0 IL69525 A0 IL 69525A0
Authority
IL
Israel
Prior art keywords
compounds
benzodioxepin
spiro
piperidine
pyrrolidino
Prior art date
Application number
IL69525A
Other languages
English (en)
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of IL69525A0 publication Critical patent/IL69525A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/48Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02Seven-membered rings
    • C07D321/10Seven-membered rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IL69525A 1982-08-20 1983-08-19 Spiro(2h-1,4-benzodioxepin-3(5h)4'piperidine and 3'-pyrrolidino)compounds,a process for preparing the same and their use as medicaments IL69525A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/410,155 US4405631A (en) 1982-08-20 1982-08-20 Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'pyrrolidine] compounds and their use as antihypertensive agents

Publications (1)

Publication Number Publication Date
IL69525A0 true IL69525A0 (en) 1983-11-30

Family

ID=23623465

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69525A IL69525A0 (en) 1982-08-20 1983-08-19 Spiro(2h-1,4-benzodioxepin-3(5h)4'piperidine and 3'-pyrrolidino)compounds,a process for preparing the same and their use as medicaments

Country Status (20)

Country Link
US (1) US4405631A (el)
EP (1) EP0102034B1 (el)
JP (1) JPS5953489A (el)
KR (1) KR840005729A (el)
AT (1) ATE33656T1 (el)
AU (1) AU576473B2 (el)
CA (1) CA1210764A (el)
DE (1) DE3376327D1 (el)
DK (1) DK381983A (el)
ES (2) ES8505685A1 (el)
FI (1) FI832959A (el)
GR (1) GR78667B (el)
HU (1) HU191874B (el)
IL (1) IL69525A0 (el)
MA (1) MA19881A1 (el)
NO (1) NO833001L (el)
NZ (1) NZ205320A (el)
PH (1) PH18839A (el)
PT (1) PT77223B (el)
ZA (1) ZA836127B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472580A (en) * 1982-08-20 1984-09-18 Hoechst-Roussel Pharmaceuticals Incorporated Spiro (2H-1,4-benzodioxepin-3 (5H)4-piperidine and -3-pyrrolidine) compounds and their use as anti-hypertensive agents
US4521537A (en) * 1982-08-20 1985-06-04 Hoechst-Roussel Pharmaceuticals Incorporated Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'-pyrrolidine] compounds and their use as antihypertensive agents
US4751223A (en) * 1986-10-14 1988-06-14 Hoechst-Roussel Pharmaceuticals, Inc. Antiinflammatory and analgesic aminoalkyl tetracyclic benzodiazepines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1312894A (fr) * 1962-01-29 1962-12-21 Geigy Ag J R Nouveaux composés hétérocycliques à 2 atomes d'oxygène dans le cycle et leur préparation
CH469736A (de) * 1966-06-28 1969-03-15 Geigy Ag J R Verfahren zur Herstellung von neuen Heterospiroalkanen
US3679666A (en) * 1969-04-03 1972-07-25 Hoffmann La Roche 4-(4-hydroxypiperidino)-4'-fluorobutyrophenones

Also Published As

Publication number Publication date
EP0102034B1 (en) 1988-04-20
CA1210764A (en) 1986-09-02
PH18839A (en) 1985-10-10
NO833001L (no) 1984-02-21
AU576473B2 (en) 1988-09-01
PT77223A (en) 1983-09-01
DK381983A (da) 1984-02-21
US4405631A (en) 1983-09-20
GR78667B (el) 1984-09-27
EP0102034A1 (en) 1984-03-07
MA19881A1 (fr) 1984-04-01
ES525013A0 (es) 1985-06-01
PT77223B (en) 1986-03-18
KR840005729A (ko) 1984-11-16
FI832959A0 (fi) 1983-08-18
DK381983D0 (da) 1983-08-19
FI832959A (fi) 1984-02-21
ZA836127B (en) 1984-04-25
ATE33656T1 (de) 1988-05-15
HU191874B (en) 1987-04-28
JPS5953489A (ja) 1984-03-28
ES540841A0 (es) 1985-12-01
AU1816983A (en) 1984-02-23
NZ205320A (en) 1987-05-29
ES8505685A1 (es) 1985-06-01
DE3376327D1 (en) 1988-05-26
ES8602800A1 (es) 1985-12-01

Similar Documents

Publication Publication Date Title
MY102038A (en) 4-substituted androstendione derivatives and process for their preparation
EG17753A (en) Novel pharmacological compounds
PL314086A1 (en) Novel (r)-8-fluoro-3-n,n-substituted amino 3,4-dihydro 5-carbamoyl-2h-1-bezopyranes
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
ES8608524A1 (es) Procedimiento para preparar 5h, 11h-pirrolo (2, 1-c)-(1, 4) benzoxazepinas sustituidas en posicion 11
IL69525A0 (en) Spiro(2h-1,4-benzodioxepin-3(5h)4'piperidine and 3'-pyrrolidino)compounds,a process for preparing the same and their use as medicaments
ES8707738A1 (es) Un procedimiento para la preparacion de 1-metil-4,5-dihidroorotil-histidil-prolinamida
AU576914B2 (en) 5-cyanopyridine-2-diazohydroxide, basic salts thereof
ES8601200A1 (es) Un procedimiento para preparar compuestos de 3-(2-haloetil)-4-oxopirazolo-(5, 1-d)-1, 2, 3, 5-tetrazin-8-carboxamida
JO1531B1 (en) New near-compounds